Latest Breaking News On - Invitae pharmacogenomics - Page 1 : comparemela.com

/PRNewswire/ Invitae (NYSE: NVTA), a leading medical genetics company, today announced the commercial availability of the expanded Invitae Pharmacogenomics.

United statesKristine ashcraftDrug administrationInvitae pharmacogenomics pgx panelUs census bureauInvitae pharmacogenomics mental health panelExchange commissionInvitae corporationInvitae youscript precision prescribing softwareInvitae pharmacogenomics panelClinical pharmacogenetics implementation consortiumInvitae pharmacogenomicsDrug dose now actYouscript precision prescribing softwarePharmacogenomics mental health panelPrivate securities litigation reform act